Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
The American Journal of Surgical Pathology|September 18, 2015
Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 RearrangementsRebecca L King, Linda N Dao, Ellen D McPhail, et al.
Human Pathology|November 18, 2023
Identification of amyloidosis of the urinary tract and prostate: Opportunities for early diagnosis & intervention in systemic diseaseSarwat I Gilani, Surendra Dasari, Burak Tekin, et al.
Leukemia|November 30, 2019
IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological featuresSurbhi Sidana, Daniel P Larson, Patricia T Greipp, et al.
Kidney International|February 1, 2020
Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell cloneSamih H Nasr, Christopher P Larsen, Christophe Sirac, et al.
The Oncologist|August 14, 2015
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41)Amie E Jackson, Michael Mian, Christina Kalpadakis, et al.
Kidney International Reports|January 18, 2018
DNAJB9 Is a Specific Immunohistochemical Marker for Fibrillary GlomerulonephritisSamih H Nasr, Julie A Vrana, Surendra Dasari, et al.
Hematological Oncology|May 31, 2023
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomasMelissa A Hopper, Kerstin Wenzl, Keenan T Hartert, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 15, 2024
Clinicopathologic, Proteomic and Outcome Characteristics of Renal Apolipoprotein C-II Amyloidosis: A Case SeriesSamih H Nasr, Surendra Dasari, Anthony M Valeri, et al.
Kidney International|December 29, 2022
Pathological characteristics of light chain crystalline podocytopathySamih H Nasr, Satoru Kudose, Vincent Javaugue, et al.
American Journal of Hematology|October 29, 2017
MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemiaJithma P Abeykoon, Jonas Paludo, Rebecca L King, et al.
Pageof 10